Literature DB >> 31726863

Survival and Integration of Transplanted Olfactory Ensheathing Cells are Crucial for Spinal Cord Injury Repair: Insights from the Last 10 Years of Animal Model Studies.

Ronak Reshamwala1,2,3, Megha Shah2,3, James St John1,2,3, Jenny Ekberg1,2,3.   

Abstract

Olfactory ensheathing cells (OECs), the glial cells of the primary olfactory nervous system, support the natural regeneration of the olfactory nerve that occurs throughout life. OECs thus exhibit unique properties supporting neuronal survival and growth. Transplantation of OECs is emerging as a promising treatment for spinal cord injury; however, outcomes in both animals and humans are variable and the method needs improvement and standardization. A major reason for the discrepancy in functional outcomes is the variability in survival and integration of the transplanted cells, key factors for successful spinal cord regeneration. Here, we review the outcomes of OEC transplantation in rodent models over the last 10 years, with a focus on survival and integration of the transplanted cells. We identify the key factors influencing OEC survival: injury type, source of transplanted cells, co-transplantation with other cell types, number and concentration of cells, method of delivery, and time of transplantation after the injury. We found that two key issues are hampering optimization and standardization of OEC transplantation: lack of (1) reliable methods for identifying transplanted cells, and (2) three-dimensional systems for OEC delivery. To develop OEC transplantation as a successful and standardized therapy for spinal cord injury, we must address these issues and increase our understanding of the complex parameters influencing OEC survival.

Entities:  

Keywords:  cell integration; cell survival; glial cells; olfactory ensheathing cells; spinal cord injury

Year:  2019        PMID: 31726863      PMCID: PMC7016467          DOI: 10.1177/0963689719883823

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  139 in total

1.  Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation.

Authors:  Liudmila N Novikova; Sergei Lobov; Mikael Wiberg; Lev N Novikov
Journal:  Exp Neurol       Date:  2010-10-13       Impact factor: 5.330

2.  Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.

Authors:  X W Kang; J L Hu; S K Wang; J Wang
Journal:  Genet Mol Res       Date:  2015-10-28

3.  Olfactory ensheathing cells, olfactory nerve fibroblasts and biomatrices to promote long-distance axon regrowth and functional recovery in the dorsally hemisected adult rat spinal cord.

Authors:  R Deumens; G C Koopmans; W M M Honig; F P T Hamers; V Maquet; R Jérôme; H W M Steinbusch; E A J Joosten
Journal:  Exp Neurol       Date:  2006-03-09       Impact factor: 5.330

4.  Implications of olfactory lamina propria transplantation on hyperreflexia and myelinated fiber regeneration in rats with complete spinal cord transection.

Authors:  Lígia Aline Centenaro; Mariane da Cunha Jaeger; Jocemar Ilha; Marcelo Alves de Souza; Luciane Fachin Balbinot; Patrícia Severo do Nascimento; Simone Marcuzzo; Matilde Achaval
Journal:  Neurochem Res       Date:  2012-11-25       Impact factor: 3.996

5.  Autologous olfactory ensheathing cell transplantation in human spinal cord injury.

Authors:  F Féron; C Perry; J Cochrane; P Licina; A Nowitzke; S Urquhart; T Geraghty; A Mackay-Sim
Journal:  Brain       Date:  2005-10-11       Impact factor: 13.501

6.  Transplantation of Cultured Olfactory Bulb Cells Prevents Abnormal Sensory Responses During Recovery From Dorsal Root Avulsion in the Rat.

Authors:  Andrew Collins; Daqing Li; Stephen B McMahon; Geoffrey Raisman; Ying Li
Journal:  Cell Transplant       Date:  2017-03-23       Impact factor: 4.064

7.  Scar ablation combined with LP/OEC transplantation promotes anatomical recovery and P0-positive myelination in chronically contused spinal cord of rats.

Authors:  Shu-Xin Zhang; Fengfa Huang; Mary Gates; Eric G Holmberg
Journal:  Brain Res       Date:  2011-05-31       Impact factor: 3.252

8.  The cellular inflammatory response in human spinal cords after injury.

Authors:  Jennifer C Fleming; Michael D Norenberg; David A Ramsay; Gregory A Dekaban; Alexander E Marcillo; Alvaro D Saenz; Melissa Pasquale-Styles; W Dalton Dietrich; Lynne C Weaver
Journal:  Brain       Date:  2006-10-28       Impact factor: 13.501

9.  Immunocytological localization of the major peripheral nervous system glycoprotein P0 and the L2/HNK-1 and L3 carbohydrate structures in developing and adult mouse sciatic nerve.

Authors:  R Martini; E Bollensen; M Schachner
Journal:  Dev Biol       Date:  1988-10       Impact factor: 3.582

10.  OECs transplantation results in neuropathic pain associated with BDNF regulating ERK activity in rats following cord hemisection.

Authors:  Bing-Chen Lang; Zhuo Zhang; Long-Yun Lv; Jin Liu; Ting-Yong Wang; Ling-Hui Yang; Da-Qing Liao; Wen-Sheng Zhang; Ting-Hua Wang
Journal:  BMC Neurosci       Date:  2013-08-02       Impact factor: 3.288

View more
  11 in total

1.  Human Olfactory Ensheathing Cell-derived Extracellular Cesicles: miRNA Profile and Neuroprotective Effect.

Authors:  Yuan-Kun Tu; Yu-Huan Hsueh; Hsien-Chang Huang
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

Review 2.  Fractone Stem Cell Niche Components Provide Intuitive Clues in the Design of New Therapeutic Procedures/Biomatrices for Neural Repair.

Authors:  James Melrose
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

3.  Nanohydroxyapatite as a Biomaterial for Peripheral Nerve Regeneration after Mechanical Damage-In Vitro Study.

Authors:  Benita Wiatrak; Paulina Sobierajska; Marta Szandruk-Bender; Paulina Jawien; Maciej Janeczek; Maciej Dobrzynski; Patrycja Pistor; Adam Szelag; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

4.  Transplantation of sh-miR-199a-5p-Modified Olfactory Ensheathing Cells Promotes the Functional Recovery in Rats with Contusive Spinal Cord Injury.

Authors:  Zhengchao Gao; Yingjie Zhao; Xijing He; Zikuan Leng; Xiaoqian Zhou; Hui Song; Rui Wang; Zhongyang Gao; Yiqun Wang; Jiantao Liu; Binbin Niu; Haopeng Li; Pengrong Ouyang; Su'e Chang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 5.  Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.

Authors:  Małgorzata Zawadzka; Anna Kwaśniewska; Krzysztof Miazga; Urszula Sławińska
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 6.  Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults.

Authors:  Artem Sinegubov; Daria Andreeva; Nikita Burzak; Maria Vasyutina; Lada Murashova; Vyacheslav Dyachuk
Journal:  Front Mol Neurosci       Date:  2022-03-25       Impact factor: 5.639

7.  Macrophages Treated with VEGF and PDGF Exert Paracrine Effects on Olfactory Ensheathing Cell Function.

Authors:  Souptik Basu; Indra N Choudhury; Jia Yu Peppermint Lee; Anu Chacko; Jenny A K Ekberg; James A St John
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

Review 8.  Designing Olfactory Ensheathing Cell Transplantation Therapies: Influence of Cell Microenvironment.

Authors:  Mariyam Murtaza; Lipsa Mohanty; Jenny A K Ekberg; James A St John
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

9.  High-Yield Mucosal Olfactory Ensheathing Cells Restore Loss of Function in Rat Dorsal Root Injury.

Authors:  Kamile Minkelyte; Andrew Collins; Modinat Liadi; Ahmed Ibrahim; Daqing Li; Ying Li
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

10.  Comparison of the effects of two therapeutic strategies based on olfactory ensheathing cell transplantation and repetitive magnetic stimulation after spinal cord injury in female mice.

Authors:  Quentin Delarue; Amandine Robac; Romane Massardier; Jean-Paul Marie; Nicolas Guérout
Journal:  J Neurosci Res       Date:  2021-05-07       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.